Patient with hepatocellular carcinoma on the waiting list for liver transplantation: abdominal seeding due to prior surgery: a case report.
Hepatocellular cancer (HCC) is the most common primary malignant hepatic tumor that accounts for over 80% of primary liver tumors. Hepatic resection is a well-accepted therapy for HCC, but 70% to 100% of patients, depending on patient selection, baseline tumor characteristics, and follow-up duration, develop cancer recurrence after resective surgery. Orthotropic liver transplantation is considered more appropriate in cases with HCC related to cirrhosis. Both procedures may result in recurrence. In some cases, diagnosis of recurrent HCC is difficult because of unexpected localization of the tumor. For these patients, aggressive diagnostic tests might be useful for appropriate therapy. We report a case of a 48-year-old man undergoing resection for HCC, who experienced early recurrence of HCC in the pelvic region.
Aydin
U
U
Ege University School of Medicine, Organ Transplantation and Research Center, Izmir, Turkey. drunalaydin@yahoo.com
Yazici
P
P
Sozbilen
M
M
Kece
C
C
Tamsel
S
S
Kilic
M
M
D006528:Carcinoma, Hepatocellular / Q000473:pathology / Q000601:surgery*; D006509:Hepatitis B / Q000150:complications; D017325:Hepatitis B Vaccines; D006801:Humans; D008113:Liver Neoplasms / Q000473:pathology / Q000601:surgery*; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011183:Postoperative Complications; D012008:Recurrence; D014850:Waiting Lists
D017325:Hepatitis B Vaccines